Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 4 | Misra AmitabhChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $243K 41.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Samuelson Errol GChief Industry Dev. Officer | Grant or award · 10b5-1 plan | A | — 7,912 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | — 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | $12K 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | $233K 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 7,188 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Derivative conversion | C | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | $21K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 4,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 3,475 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | — 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Owens Bradley D.General Counsel | Option exercise · 10b5-1 plan | M | — 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 2,896 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | — 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 56 | Menell Richard PeterDirector | Open-market purchase | BUY | $29K 2,500 sh | Mar 25, 2026 traded Mar 24, 2026 |
| 50 | Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER | Open-market purchase | BUY | $125K 213.3K sh | Mar 25, 2026 traded Mar 13, 2026 |
| 47 | Angel MatthewDirector, CEO and President, 10% Owner | Open-market purchase | BUY | $500K 231.5K sh | Mar 25, 2026 traded Mar 24, 2026 |
| 44 | Armstrong Courtney DDirector | Open-market purchase | BUY | $3,980 16 sh | Mar 25, 2026 traded Nov 25, 2025 |
| 44 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $1.03M 12.6K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 43 | Keyter CharlDirector, Chief Financial Officer | Open-market purchase | BUY | $95K 35.0K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 42 | Parker Austin ColbyCFO and Treasurer | Open-market purchase | BUY | $36K 2,500 sh | Mar 25, 2026 traded Mar 25, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $431K 5,140 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 39 | Serero Liron NetanelaSee remarks | Open-market purchase | BUY | $6,400 5,000 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 39 | Rotshten ClaireEVP of Finance | Open-market purchase | BUY | $13K 10.0K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 39 | Yekutiel RonDirector, Chief Executive Officer | Open-market purchase | BUY | $50K 40.0K sh | Mar 25, 2026 traded Mar 24, 2026 |
| 38 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $99K 1,187 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 38 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $131K 1,541 sh | Mar 25, 2026 traded Mar 23, 2026 |